These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10378123)

  • 1. Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease--inverse correlation.
    Bakalova R; Zhelev Z; Goudev A; Ribarov S; Nachev C
    Gen Physiol Biophys; 1999 Mar; 18(1):87-97. PubMed ID: 10378123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation of low density lipoproteins leads to disturbance of their binding with alpha-tocopherol.
    Bakalova RA; Goudev AR; Zhelev ZZ; Nachev C; Ribarov SR
    Gen Physiol Biophys; 1996 Dec; 15(6):463-75. PubMed ID: 9248832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodetection of modified lipoproteins in plasma and arterial walls of patients with coronary heart disease.
    Sima A; Stancu C; Starodub O; Cristea C; Simionescu M
    Rom J Intern Med; 1997; 35(1-4):29-38. PubMed ID: 9562650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A; Hulthe J; Rosengren A; Wiklund O; Wilhelmsen L
    Clin Sci (Lond); 2001 Nov; 101(5):523-31. PubMed ID: 11672458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques.
    Gonçalves I; Gronholdt ML; Söderberg I; Ares MP; Nordestgaard BG; Bentzon JF; Fredrikson GN; Nilsson J
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1250-5. PubMed ID: 15831809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein oxidation and plasma vitamin E in nondiabetic normotensive obese patients.
    Myara I; Alamowitch C; Michel O; Heudes D; Bariety J; Guy-Grand B; Chevalier J
    Obes Res; 2003 Jan; 11(1):112-20. PubMed ID: 12529493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new enzyme-linked immunosorbent assay for oxidized lipoprotein(a) by using purified human oxidized lipoprotein(a) autoantibodies as capture antibody.
    Wang J; Zhang C; Gong J; Zhu Y; Fu L; Wang X; Li K
    Clin Chim Acta; 2007 Oct; 385(1-2):73-8. PubMed ID: 17719023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease.
    Luoma JS; Kareinen A; Närvänen O; Viitanen L; Laakso M; Ylä-Herttuala S
    Free Radic Biol Med; 2005 Dec; 39(12):1660-5. PubMed ID: 16298691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody against oxidized low-density lipoprotein predicting myocardial infarction.
    Puurunen M; Mänttäri M; Manninen V; Tenkanen L; Alfthan G; Ehnholm C; Vaarala O; Aho K; Palosuo T
    Arch Intern Med; 1994 Nov; 154(22):2605-9. PubMed ID: 7979858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
    Liang KW; Huang JL; Kao CH; Hsueh CW; Ho HY; Lee WL; Wang KY; Huang DS; Chen YT; Ting CT
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.